Recombinant Nipah virus Glycoprotein G (G)-VLPs

Basic Research Questions

• What is Nipah virus Glycoprotein G and what is its structural composition?

  Nipah virus glycoprotein G is a critical surface protein with a distinctive globular head domain formed of a six-bladed beta sheet-propeller, connected to a transmembrane anchor via a flexible stalk domain . This protein is responsible for viral attachment to host cells by binding specifically to cellular receptors ephrin B2 and ephrin B3 . The recombinant form of this protein typically comprises amino acids 71-602 of the native sequence and may incorporate various tags (such as human Fc) to facilitate purification and detection . When visualized through SDS-PAGE analysis, the protein typically migrates as a band of approximately 100-110kDa, reflecting its glycosylated state and fusion tag contribution . The crystal structure of NiV-G has been determined both in its receptor-unbound state and in complex with ephrin-B3, providing critical insights into its binding mechanism and conformational dynamics .

• How are Nipah virus Glycoprotein G-containing VLPs generated in laboratory settings?

  Nipah virus Glycoprotein G-containing VLPs can be generated through several methodological approaches:

  • Plasmid-based expression systems: Researchers can transfect cells with plasmids encoding NiV structural proteins including glycoprotein G (G), fusion protein (F), and matrix protein (M) . The Institute of Advanced Virology has developed systems using HiBiT-tagged constructs to facilitate detection and analysis .

  • Recombinant viral vector systems: Modified vaccinia viruses (such as LC16m8 strain) can be engineered to express NiV glycoprotein G, as demonstrated in recent studies where recombinant vaccinia viruses expressing NiV G or F proteins successfully induced neutralizing antibodies in animal models .

  • Individual protein expression: Interestingly, individual expression of M, F, or G proteins can independently result in detectable membrane-associated protein release, though co-expression of multiple proteins yields VLPs with characteristics more similar to authentic virions .

  After expression, VLPs can be isolated from culture supernatants through differential centrifugation, typically involving pelleting through a sucrose cushion followed by flotation in a discontinuous sucrose gradient to purify membrane-associated particles .

• What methods are used to verify the identity and integrity of recombinant Nipah virus Glycoprotein G?

  Multiple complementary techniques are employed to verify recombinant G protein:

  • SDS-PAGE analysis: Reducing conditions typically show the protein migrating as a band of approximately 100-110kDa .

  • Immunoprecipitation: Using specific antibodies against NiV-G to confirm protein identity in both cell lysates and membrane fractions .

  • Immunoelectron microscopy: Gold-labeled antibodies against NiV-G can visualize the protein in purified VLPs, confirming both its presence and proper incorporation into particles .

  • Functional binding assays: Verification that the recombinant G protein maintains its ability to bind ephrin B2/B3 receptors is essential for confirming biological activity .

  • Purity assessment: Commercial preparations typically specify >90% purity suitable for further applications .

• What cell lines are preferred for recombinant Nipah virus Glycoprotein G expression?

  HEK293 cells are predominantly used for recombinant Nipah virus Glycoprotein G expression . This mammalian expression system offers several advantages for viral glycoprotein production:

  • Provides appropriate post-translational modifications, especially glycosylation patterns that may be critical for proper folding and function

  • Supports efficient secretion of the recombinant protein when appropriate signal sequences are included

  • Enables the production of properly folded complex proteins with native-like conformation

  • Can achieve reasonable yields with >90% purity for research applications

  The choice of expression system significantly impacts protein quality. When expressing the full ectodomain (amino acids 71-602), the HEK293 system ensures proper disulfide bond formation and glycosylation necessary for maintaining the six-bladed beta-propeller structure of the head domain .

Advanced Research Questions

• How does the interaction between Nipah virus Glycoprotein G and ephrin receptors mechanistically facilitate membrane fusion?

  The mechanism involves a precisely orchestrated sequence of molecular events:

  1. The NiV-G protein initially binds to either ephrin-B2 or ephrin-B3 receptors on the target cell surface through its globular head domain .

  2. This binding event triggers a conformational change in the G protein structure . Crystal structure analysis has revealed the specific interaction interfaces and conformational changes involved in this process .

  3. The conformational change in G protein subsequently activates the fusion (F) protein, which undergoes its own dramatic structural rearrangement .

  4. This F protein refolding provides the energy needed to overcome the repulsive forces between viral and cellular membranes, driving the fusion process .

  The highly specific interactions between NiV-G and only two members (ephrin-B2 and ephrin-B3) of the large ephrin family are due to particular structural features at the binding interface. These structures suggest potential targets for therapeutic intervention, as disrupting the G-ephrin interaction could effectively block viral entry . Recombinant G proteins that maintain these binding characteristics are valuable tools for studying this process and developing inhibitors.

• What are the optimal sucrose gradient conditions for isolating pure Nipah virus Glycoprotein G-containing VLPs?

  Based on systematic studies, the following gradient methodology has been established for optimal VLP isolation:

  1. Initial clarification: Culture supernatants should first be cleared of cellular debris through low-speed centrifugation (typically 3,000×g for 10 minutes) .

  2. Concentration: VLPs can be pelleted through a 10% sucrose cushion using ultracentrifugation (typically 100,000×g for 2 hours) .

  3. Purification: For analytical separation, 5-45% continuous sucrose gradients are effective, with centrifugation at 100,000×g for 16-18 hours .

  4. Collection: For G-containing VLPs, peak fractions typically occur at densities between 1.15-1.18 g/ml when co-expressed with M protein .

  5. Verification: Each fraction should be analyzed by immunoprecipitation and SDS-PAGE to confirm protein content and purity .

  It's noteworthy that VLPs containing only G and F proteins tend to band at slightly higher densities (1.18-1.21 g/ml) than those also containing M protein, which shifts their density profile closer to authentic virions (1.15 g/ml) . This density shift provides a useful quality control parameter for VLP preparation.

• How can recombinant Nipah virus Glycoprotein G expression systems be optimized for maximum yield and functionality?

  Optimization strategies for recombinant NiV-G expression include:

  1. Construct design considerations:

     • The inclusion of amino acids 71-602 appears optimal for maintaining proper protein folding while removing the transmembrane domain to enhance secretion

     • C-terminal tagging (such as human Fc) is preferable as it minimizes interference with receptor binding domains

     • Codon optimization for the expression host can significantly improve translation efficiency

  2. Expression conditions:

     • Temperature reduction to 30-32°C during expression phase can improve folding of complex proteins

     • Supplementation with specific glycosylation inhibitors can be used to study the role of glycans in protein function

     • Serum reduction strategies during production phase can simplify downstream purification

  3. Purification strategies:

     • For Fc-tagged constructs, Protein A/G affinity chromatography provides high selectivity

     • Size exclusion chromatography as a polishing step helps remove aggregates

     • Maintaining appropriate buffer conditions with stabilizers prevents degradation

  These optimization approaches must be balanced with maintaining proper protein conformation and function, as evidenced by receptor binding assays and structural integrity assessment.

• What are the comparative advantages of different VLP systems for studying Nipah virus immunogenicity?

  Different VLP systems offer distinct advantages for immunological studies:

  VLP System	Immunological Advantages	Limitations	Applications
  LC16m8-based vaccinia expressing NiV-G	Higher neutralizing antibody titers than other poxvirus vectors; Proliferative vaccine capabilities	Requires live virus vector	Preventive vaccine development
  Plasmid-based VLPs with multiple NiV proteins	Most authentic particle morphology; Contains multiple antigens	Lower yield than single protein systems	Structural studies; Comprehensive antibody induction
  HiBiT-tagged NiV-VLPs	Enhanced detection sensitivity; Non-infectious	May introduce tag artifacts	Antiviral screening; Monoclonal antibody development
  Recombinant G protein (non-VLP)	Simplified production; Focused immune response	Lacks membrane context	Immunoassay development; Receptor binding studies

  Recent advances using HiBiT-tagged NiV-VLPs generated through plasmid-based expression systems have shown particular promise for developing monoclonal antibodies and screening antivirals against NiV infection . The choice of system should be guided by the specific research question, with comprehensive immunity studies benefiting from multi-protein VLPs that better mimic authentic virions.

• What methodologies can determine the conformational changes in Nipah virus Glycoprotein G upon receptor binding?

  Several sophisticated methodologies can be employed to study the critical conformational changes in NiV-G:

  1. X-ray crystallography: Has successfully revealed the structures of both unbound NiV-G and the G-ephrin-B3 complex, providing atomic-level insight into binding-induced conformational changes .

  2. Cryo-electron microscopy: Can visualize the G protein in the context of intact VLPs before and after receptor binding, preserving native membrane association.

  3. Hydrogen-deuterium exchange mass spectrometry (HDX-MS): Provides information about protein dynamics and solvent accessibility changes upon receptor binding.

  4. Site-directed mutagenesis combined with functional assays: Systematic mutation of key residues followed by binding and fusion assays can map functional domains involved in conformational switching.

  5. FRET-based biosensors: Can be designed to detect real-time conformational changes when appropriately placed fluorophores are engineered into the G protein structure.

  Crystal structures have already revealed that NiV-G has a unique binding mode with ephrins that likely influences how it mediates both attachment and fusion triggering . These methodologies, particularly when used in combination, can further elucidate the molecular mechanisms of this process and identify potential sites for therapeutic intervention.